This month brings us yet another health update. Short summary: everything is fine. My immune system has recovered and all my other counts are in the normal range. I’ve been off the dex for two months and off the sleeping meds for the past week (after tapering off for a month). I still have some residual fatigue from my monthly infusion of the primary chemo drug, but it’s not too bad.

As for the multiple myeloma itself, the latest test shows that my cancer load is slightly up from last month:

This is nothing to worry about. We expected the number to go up a bit after I stopped the dex, and 0.36 is still lower than the readings I had for two years on the old medication. As long as the M-protein number flattens out below 0.5, I’m doing great.

YOUR GIFT DOUBLES THROUGH FRIDAY

Right now, every dollar you give goes twice as far—but only until Friday’s midnight deadline. This is the moment to make your support count double.

In a climate where journalists face mounting pressure to back down, stay silent, or soften their reporting, Mother Jones refuses to flinch. We’re pushing back against intimidation and delivering fierce, independent journalism that holds power accountable—no matter who’s trying to silence us.

But here’s the reality: We’re a nonprofit newsroom with zero corporate backing and no financial cushion. We depend entirely on readers like you to fund the investigations that matter most.

Friday’s 2X match deadline is coming soon. We need you on the team right now. Please chip in and double your impact.

YOUR GIFT DOUBLES THROUGH FRIDAY

Right now, every dollar you give goes twice as far—but only until Friday’s midnight deadline. This is the moment to make your support count double.

In a climate where journalists face mounting pressure to back down, stay silent, or soften their reporting, Mother Jones refuses to flinch. We’re pushing back against intimidation and delivering fierce, independent journalism that holds power accountable—no matter who’s trying to silence us.

But here’s the reality: We’re a nonprofit newsroom with zero corporate backing and no financial cushion. We depend entirely on readers like you to fund the investigations that matter most.

Friday’s 2X match deadline is coming soon. We need you on the team right now. Please chip in and double your impact.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate